Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design.

Molecular Pharmaceutics
Sara G T PereiraWafa T Al-Jamal

Abstract

L-377,202 prodrug (Dox-PSA) was in phase I clinical trials for patients with metastatic castration-resistant prostate cancer (mCRPC). It consists of doxorubicin (Dox) conjugated to a prostate specific antigen (PSA)-cleavable peptide that can be selectively activated by secreted PSA at the tumor site. However, despite the initial promising results, further clinical testing with Dox-PSA was halted due to toxicity concerns emerging from non-PSA-specific cleavage, following systemic administration. In the present study, we have reported, for the first time, the intracellular activation of Dox-PSA, where Dox nuclear uptake was specific to C4-2B (PSA-expressing) cells, which agreed with the cytotoxicity studies. This finding was confirmed by encapsulating Dox-PSA prodrug into pH-sensitive liposomes to enable prodrug intracellular release, followed by its enzymatic activation. Interestingly, our results demonstrated that Dox-PSA loaded into pH-responsive nanoparticles exhibited cytotoxicity comparable to free prodrug in C4-2B monolayers, with superior activity in tumor spheroids, due to deeper penetration within tumor spheroids. Our approach could open the doors for novel Dox-PSA nanomedicines with higher safety and efficacy to treat ...Continue Reading

References

Jan 1, 1984·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·J Carlsson, J M Yuhas
Mar 14, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·W ZaunerA M Haines
Oct 13, 2001·Biochimica Et Biophysica Acta·S SimõesM C Pedroso de Lima
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert S DiPaolaSiu-Long Yao
Aug 6, 2002·Bioorganic & Medicinal Chemistry Letters·Annastasiah MhakaSaeed R Khan
May 3, 2003·Methods in Molecular Medicine·Pamela J Russell, Elizabeth A Kingsley
Jul 3, 2003·Journal of the National Cancer Institute·Samuel R DenmeadeJohn T Isaacs
Jan 3, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ulrich S HuthRegine Peschka-Süss
Apr 14, 2007·The Journal of Pharmacy and Pharmacology·H Karanth, R S R Murthy
Jan 26, 2008·Nature Reviews. Drug Discovery·Jarkko RautioJouko Savolainen
Mar 14, 2008·Nature Reviews. Cancer·Hans LiljaAndrew J Vickers
Jun 6, 2009·Cellular and Molecular Life Sciences : CMLS·Hervé Hillaireau, Patrick Couvreur
Aug 18, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·Emily Ho, Yang Song
Oct 22, 2009·Small·Ayush Verma, Francesco Stellacci
Jul 3, 2010·Pharmaceutical Research·Stuart IbsenSadik Esener
Mar 12, 2011·The Prostate·Simon A WilliamsSamuel R Denmeade
Oct 1, 2011·The Prostate·Parmita SaxenaLucia R Languino
Jan 13, 2012·Journal of Cancer Research and Clinical Oncology·Linlin ZhangDalin He
Mar 9, 2012·Theranostics·Ki Young ChoiXiaoyuan Chen
Aug 15, 2012·Integrative Biology : Quantitative Biosciences From Nano to Macro·J N MockB S Cummings
Jun 19, 2013·Scientific Reports·Sungsook AhnSang Joon Lee
Dec 24, 2013·Biochimica Et Biophysica Acta·Fan YangSteven Henikoff
Apr 25, 2014·Journal of Biomolecular Screening·Angelika WalzlHelmut Dolznig
Jun 1, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ashutosh BarveKun Cheng
Jul 10, 2014·The AAPS Journal·Irene GiangGregory M K Poon
Oct 2, 2014·The AAPS Journal·Jennica L Zaro
Jul 7, 2015·Journal of Biological Methods·David Cunningham, Zongbing You
Sep 19, 2015·Journal of Biomolecular Screening·Andrew SingleAugustine Chen
Oct 30, 2016·Journal of Drug Targeting·Keren Turjeman, Yechezkel Barenholz

❮ Previous
Next ❯

Citations

Apr 16, 2021·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Lital CohenYehuda G Assaraf

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Guru SonpavdeMatthew D Galsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Robert S DiPaolaSiu-Long Yao
Annals of Oncology : Official Journal of the European Society for Medical Oncology
M D MichaelsonM R Smith
© 2022 Meta ULC. All rights reserved